67 related articles for article (PubMed ID: 21480341)
1. CD13: Waving the flag for a novel cancer stem cell target.
Christ B; Stock P; Dollinger MM
Hepatology; 2011 Apr; 53(4):1388-90. PubMed ID: 21480341
[TBL] [Abstract][Full Text] [Related]
2. CD13 is a therapeutic target in human liver cancer stem cells.
Haraguchi N; Ishii H; Mimori K; Tanaka F; Ohkuma M; Kim HM; Akita H; Takiuchi D; Hatano H; Nagano H; Barnard GF; Doki Y; Mori M
J Clin Invest; 2010 Sep; 120(9):3326-39. PubMed ID: 20697159
[TBL] [Abstract][Full Text] [Related]
3. BC-02 eradicates liver cancer stem cells by upregulating the ROS-dependent DNA damage.
Dou C; Fang C; Zhao Y; Fu X; Zhang Y; Zhu D; Wu H; Liu H; Zhang J; Xu W; Liu Z; Wang H; Li D; Wang X
Int J Oncol; 2017 Dec; 51(6):1775-1784. PubMed ID: 29039459
[TBL] [Abstract][Full Text] [Related]
4. Combination of 5-fluorouracil and genistein induces apoptosis synergistically in chemo-resistant cancer cells through the modulation of AMPK and COX-2 signaling pathways.
Hwang JT; Ha J; Park OJ
Biochem Biophys Res Commun; 2005 Jul; 332(2):433-40. PubMed ID: 15896711
[TBL] [Abstract][Full Text] [Related]
5. Recurrence cancer stem cells--made by cell fusion?
Dittmar T; Nagler C; Schwitalla S; Reith G; Niggemann B; Zänker KS
Med Hypotheses; 2009 Oct; 73(4):542-7. PubMed ID: 19564079
[TBL] [Abstract][Full Text] [Related]
6. Transcriptomic study of dormant gastrointestinal cancer stem cells.
Nishikawa S; Dewi DL; Ishii H; Konno M; Haraguchi N; Kano Y; Fukusumi T; Ohta K; Noguchi Y; Ozaki M; Sakai D; Satoh T; Doki Y; Mori M
Int J Oncol; 2012 Sep; 41(3):979-84. PubMed ID: 22735680
[TBL] [Abstract][Full Text] [Related]
7. RNA interference-mediated silencing of the p53 tumor-suppressor protein drastically increases apoptosis after inhibition of endogenous fatty acid metabolism in breast cancer cells.
Menendez JA; Lupu R
Int J Mol Med; 2005 Jan; 15(1):33-40. PubMed ID: 15583825
[TBL] [Abstract][Full Text] [Related]
8. Cellular response to 5-fluorouracil (5-FU) in 5-FU-resistant colon cancer cell lines during treatment and recovery.
De Angelis PM; Svendsrud DH; Kravik KL; Stokke T
Mol Cancer; 2006 May; 5():20. PubMed ID: 16709241
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of Disease: cancer stem cells--targeting the evil twin.
Trumpp A; Wiestler OD
Nat Clin Pract Oncol; 2008 Jun; 5(6):337-47. PubMed ID: 18431377
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibody to HER-2/neureceptor modulates repair of radiation-induced DNA damage and enhances radiosensitivity of human breast cancer cells overexpressing this oncogene.
Pietras RJ; Poen JC; Gallardo D; Wongvipat PN; Lee HJ; Slamon DJ
Cancer Res; 1999 Mar; 59(6):1347-55. PubMed ID: 10096569
[TBL] [Abstract][Full Text] [Related]
11. In vitro test-system for chemo- and thermosensitivity: an analysis of survival fractions and cell-cycle distributions in human Ewing's sarcomas as a modelfor tumors in pediatric oncology.
Debes A; Rommel F; Breise M; Willers R; Göbel U; Wessalowski R
Klin Padiatr; 2002; 214(4):223-9. PubMed ID: 12165906
[TBL] [Abstract][Full Text] [Related]
12. Chemosensitization and radiosensitization of human lung and colon cancers by antimitotic agent, ABT-751, in athymic murine xenograft models of subcutaneous tumor growth.
Jorgensen TJ; Tian H; Joseph IB; Menon K; Frost D
Cancer Chemother Pharmacol; 2007 May; 59(6):725-32. PubMed ID: 16967299
[TBL] [Abstract][Full Text] [Related]
13. Isolation and establishment of human tumor stem cells.
Roberts PE
Methods Cell Biol; 2008; 86():325-42. PubMed ID: 18442655
[TBL] [Abstract][Full Text] [Related]
14. Apoptosis, cell cycle progression and gene expression in TP53-depleted HCT116 colon cancer cells in response to short-term 5-fluorouracil treatment.
Adamsen BL; Kravik KL; Clausen OP; De Angelis PM
Int J Oncol; 2007 Dec; 31(6):1491-500. PubMed ID: 17982676
[TBL] [Abstract][Full Text] [Related]
15. Apoptosis signaling in cancer stem cells.
Fulda S; Pervaiz S
Int J Biochem Cell Biol; 2010 Jan; 42(1):31-8. PubMed ID: 19577660
[TBL] [Abstract][Full Text] [Related]
16. Insights into the cell of origin in breast cancer and breast cancer stem cells.
Lindeman GJ; Visvader JE
Asia Pac J Clin Oncol; 2010 Jun; 6(2):89-97. PubMed ID: 20565420
[TBL] [Abstract][Full Text] [Related]
17. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
18. Hydroxyurea and trimidox enhance the radiation effect in human pancreatic adenocarcinoma cells.
Leyden D; Ahmed N; Hassan HT
Anticancer Res; 2000; 20(1A):133-8. PubMed ID: 10769645
[TBL] [Abstract][Full Text] [Related]
19. A novel combination antimetabolite, TAS-102, exhibits antitumor activity in FU-resistant human cancer cells through a mechanism involving FTD incorporation in DNA.
Emura T; Suzuki N; Yamaguchi M; Ohshimo H; Fukushima M
Int J Oncol; 2004 Sep; 25(3):571-8. PubMed ID: 15289858
[TBL] [Abstract][Full Text] [Related]
20. Targeting cancer stem cells for more effective therapies: Taking out cancer's locomotive engine.
Winquist RJ; Boucher DM; Wood M; Furey BF
Biochem Pharmacol; 2009 Aug; 78(4):326-34. PubMed ID: 19539800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
